Armephaco JSC

Armephaco JSC Net Debt / EBITDA

The Net Debt to EBITDA of Armephaco JSC (AMP.VN) as of Oct 18, 2026 is 20.80. In the previous year, Net Debt to EBITDA was 28.25 — a change of -26.40% (lower).

Net Debt / EBITDA

20.80

YoY

-26.40%

Last updated:

Net Debt to EBITDA of Armephaco JSC is 2025 20.80 . Net Debt to EBITDA of Armephaco JSC was 2024 28.25 . It decreases by -26.40% lower compared to the previous year.

The Armephaco JSC Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2018
11.11 VND
Jan 1, 2019
8.83 VND
Jan 1, 2020
11.38 VND
Jan 1, 2021
14.29 VND
Jan 1, 2022
17.89 VND
Jan 1, 2023
19.79 VND
Jan 1, 2024
28.25 VND
Jan 1, 2025
20.80 VND
The Armephaco JSC Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
20.80-26.40%
28.25+42.75%
19.79+10.65%
17.89+25.20%
14.29+25.52%
11.38+28.85%
8.83-20.48%
11.11+36.25%
8.15-12.39%
9.31+28.88%
7.22—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

Net Debt to EBITDA of Armephaco JSC is 20.80 in 2025.

Net Debt to EBITDA of Armephaco JSC changed from 28.25 to 20.80, representing a -26.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Armephaco JSC with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Armephaco JSC

All Key Metrics — Armephaco JSC